Skip to main content
Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial

Fig. 3

Hematologic and liver function recovery by 6 months post-infusion. (A, B, C) The box plots show the levels of leukocyte (A), hemoglobin (B) and platelet (C) of all patients (Total), the patients with ongoing response (Non-PD) and the patients having progression disease and/or being deceased (PD/Death). (D, E) The box plots show the levels of aspartate aminotransferase (D) and alanine aminotransferase (E) of all patients, as well as the patients with Non-PD and PD/Death. (F) The curves display the circulating lymphocyte counts of Non-PD, PD/Death and all patients

Back to article page